.png){kind=icon}
.png){kind=icon}
Return
Trastuzumab Deruxtecan in Residual HER2-Positive Early Breast Cancer (vol 394, pg 845, 2026)
.png){kind=icon}
PRE
AI
O
DOI：.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En
Journal
IF:
78.5
Papers:
2.7W
Citations:
39.7W
Organization
No organization information available
Cited Papers